MOLECULAR BIOMARKERS AND HISTOLOGICAL PARAMETERS IMAPCT ON SURVIVAL AND RESPONSE TO FIRST- LINE SYSTEMIC THERAPY OF METASTATIC COLORECTAL CANCER PATIENTS. Radiology and Oncology, v. 53, n. 1, 21 Feb.2019.